PAR 2.13% 24.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-167

  1. 285 Posts.
    lightbulb Created with Sketch. 82
    I still think we need to partner as much as they need us - going forward in our progression I would still like to see a major Pharmaceutical partner with us, and my preference is for a US based. In my opinion helps to de risk the whole process. If we are to hit one of their major income sources namely pain killers you cant tell me they are not going to try and discredit our product. The oil companies politically protected the combustion engine cant see the Pharmaceutical companies being any different. If you don't think these companies have friends in high places you are kidding yourself. More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.005(2.13%)
Mkt cap ! $83.95M
Open High Low Value Volume
24.0¢ 24.5¢ 23.0¢ $57.94K 243.3K

Buyers (Bids)

No. Vol. Price($)
5 79974 23.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 48036 6
View Market Depth
Last trade - 13.09pm 07/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.